EcoDrugPlus

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSMSIG00000020979
Gene Symbol: IDO1
1 Cross references
113 Possible Orthologues:

Inhibitor Of Kappab Kinase Beta

Ensembl ID : ENSMSIG00000022158
Gene Symbol: IKBKB
1 Cross references
212 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSMSIG00000024596
Gene Symbol: IMPDH1
1 Cross references
348 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSMSIG00000000088
Gene Symbol: IMPDH2
1 Cross references
215 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSMSIG00000000171
Gene Symbol: INPP5D
1 Cross references
228 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSMSIG00000007338
Gene Symbol: INSR
1 Cross references
303 Possible Orthologues:

Insulin-Like Growth Factor I Receptor

Ensembl ID : ENSMSIG00000004944
Gene Symbol: IGF1R
1 Cross references
289 Possible Orthologues:

Integrin Alpha 2b

Ensembl ID : ENSMSIG00000027924
Gene Symbol: ITGA2B
1 Cross references
204 Possible Orthologues:

Integrin Alpha 4

Ensembl ID : ENSMSIG00000031526
Gene Symbol: ITGA4
1 Cross references
251 Possible Orthologues:

Integrin Alpha 5 (Fibronectin Receptor Alpha)

Ensembl ID : ENSMSIG00000010915
Gene Symbol: ITGA5
1 Cross references
284 Possible Orthologues:

Integrin Alpha V

Ensembl ID : ENSMSIG00000021553
Gene Symbol: ITGAV
1 Cross references
258 Possible Orthologues:

Integrin Beta 1 (Fibronectin Receptor Beta)

Ensembl ID : ENSMSIG00000024476
Gene Symbol: ITGB1
1 Cross references
313 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).